Table 5.

Percentage of nitric oxide (NO) inhibition (mean ± SD) observed with MGEOs 1–3 in lipopolysaccharide (LPS)-activated RAW264.7 cells incubated for 24 h with different MGEO concentrations.

Concentration (μg/mL)	MGEO-1 (Wild)	MGEO-2 (Wild)	MGEO-3 (Cultivated)	Doxorubicin *
50	105.83 ± 3.15	106.79 ± 0.89	105.19 ± 1.35
5	11.35 ± 0.89	17.39 ± 1.35	6.89 ± 0.89
0.5	15.48 ± 11.25	7.53 ± 3.59	10.07 ± 6.29
20				94.06 ± 2.65
2				6.47 ± 1.23
0.2				4.55 ± 0.89

* Positive control.